ARK Investment Management LLC
Institutional investor · Portfolio as of Q2 2022
Top Holdings354 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
TESLA INC | 1.4M | $1.1B | 6.5% | $157.53 | +45.05% | 15 qtrssince 2018-Q4 | Decreased 0 |
ZOOM COMMUNICATIONS INC | 9.6M | $1B | 6.1% | $232.09 | -51.80% | 7 qtrssince 2020-Q4 | Increased 70 |
ROKU INC | 10.1M | $962.7M | 5.7% | $158.38 | -45.00% | 13 qtrssince 2019-Q2 | Increased 75 |
BLOCK INC | 9.1M | $799.5M | 4.7% | $131.08 | -51.30% | 15 qtrssince 2018-Q4 | Increased 64 |
EXACT SCIENCES CORP | 15M | $745.7M | 4.4% | $113.08 | -64.11% | 8 qtrssince 2020-Q3 | Increased 61 |
COINBASE GLOBAL INC -CLASS A | 9M | $699.1M | 4.1% | $196.29 | -74.66% | 5 qtrssince 2021-Q2 | Increased 72 |
TELADOC HEALTH INC | 20.3M | $691.8M | 4.1% | $166.66 | -79.39% | 15 qtrssince 2018-Q4 | Increased 61 |
UIPATH INC | 37.6M | $641.8M | 3.8% | $49.22 | -59.88% | 5 qtrssince 2021-Q2 | Increased 65 |
TWILIO INC - A | 5.6M | $586.1M | 3.5% | $267.27 | -66.48% | 15 qtrssince 2018-Q4 | Increased 64 |
CRISPR THERAPEUTICS AG | 9.7M | $564.7M | 3.3% | $77.33 | -18.53% | 15 qtrssince 2018-Q4 | Increased 60 |
SHOPIFY INC - CLASS A | 1.2M | $455.2M | 2.7% | $86.90 | -61.97% | 15 qtrssince 2018-Q4 | Increased 69 |
INTELLIA THERAPEUTICS INC | 9.5M | $439M | 2.6% | $36.06 | +45.39% | 15 qtrssince 2018-Q4 | Increased 57 |
UNITY SOFTWARE INC | 9.2M | $366.8M | 2.2% | $101.19 | -60.94% | 8 qtrssince 2020-Q3 | Increased 59 |
DRAFTKINGS INC | 25.3M | $342.5M | 2.0% | $12.41 | 0.00% | 1 qtr | New 80 |
ROBINHOOD MARKETS INC - A | 33.6M | $337.6M | 2.0% | $23.90 | -64.57% | 4 qtrssince 2021-Q3 | Increased 54 |
BEAM THERAPEUTICS INC | 8.8M | $309.3M | 1.8% | $81.81 | -50.59% | 7 qtrssince 2020-Q4 | Increased 52 |
SIGNIFY HEALTH INC | 21.9M | $298.3M | 1.8% | — | — | 6 qtrssince 2021-Q1 | Increased 51 |
Ginkgo Bioworks Holdings, Inc. | 87.4M | $269.1M | 1.6% | — | — | — | — |
PAGERDUTY INC | 10.9M | $268.3M | 1.6% | $28.69 | -10.19% | 10 qtrssince 2020-Q1 | Increased 52 |
FATE THERAPEUTICS INC | 11.5M | $265M | 1.6% | $64.19 | -61.24% | 13 qtrssince 2019-Q2 | Increased 51 |
ARK Investment Management LLC manages $16.9B across 354 positions as of Q2 2022. Top holdings: TSLA (6.5%), ZM (6.1%), ROKU (5.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 5/5.0.
Active quarter - 8 new positions, 7 exits, 101 increased. Top move: DKNG (NEW, conviction 80). Portfolio: $16.9B across 354 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer